Journey Medical Corporation
DERM
Rank in Stocks
#18612
Journey Medical Corporation, a pharmaceutical firm established in Scottsdale,... Journey Medical Corporation, a pharmaceutical firm established in Scottsdale, Arizona in 2014 (and previously known as Coronado Dermatology, Inc.), is dedicated to the development and market introduction of treatments for skin conditions across the United States. Their product line encompasses key dermatological therapies such as Qbrexza, a medicated cloth wipe for managing primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug for severe, persistent acne; Targadox, an oral doxycycline medication used as an additional treatment for severe acne; Ximino, an oral minocycline drug addressing moderate to severe acne; and Exelderm, offered as a topical cream and solution. Furthermore, the company distributes doxycycline hyclate tablets, minocycline hydrochloride capsules, and sulconazole nitrate cream and solution.
Share Price
$4.52
Last synced: 2026-11-09
Market Cap
$127.57M
Change (1 day)
1.12%
Change (1 year)
-50.06%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Journey Medical Corporation (DERM)
Category
Healthcare
Operating Margin for Journey Medical Corporation (DERM)
Operating Margin as of November 2026 TTM: -4.41%
According to Journey Medical Corporation's latest financial reports, its current operating margin (TTM) is -4.41%. At the end of 2025 the company had an operating margin of -13.21%.
Operating Margin history for Journey Medical Corporation from 2014 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -4.41% | -66.62% |
| 2025 | -13.21% | -45.77% |
| 2024 | -24.36% | 829.77% |
| 2023 | -2.62% | -92.99% |
| 2022 | -37.35% | -32.40% |
| 2021 | -55.25% | -413.39% |
| 2020 | 17.63% | 17.07% |
| 2019 | 15.06% | -102.98% |
| 2018 | -505.40% | -92.36% |
| 2017 | -6,613.65% | 1,548.22% |
| 2016 | -401.26% | -63.28% |
| 2015 | -1,092.74% | 151.66% |
| 2014 | -434.22% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 19.41% | -104.40% |
DE
|
|
| 19.68% | -104.46% |
DE
|
|
| 13.26% | -103.01% |
JP
|
|
| 17.08% | -103.87% |
CH
|
|
| 14.92% | -103.38% |
IL
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about Journey Medical Corporation's operating margin
What is Journey Medical Corporation's operating margin?
Journey Medical Corporation's operating margin is -4.41%, as of Nov 2026.
What was Journey Medical Corporation's operating margin in 2025?
In 2025, Journey Medical Corporation's operating margin was -13.21%, compared with -24.36% in 2024.
How has Journey Medical Corporation's operating margin changed since 2020?
From 2020 to 2025, Journey Medical Corporation's operating margin was highest in 2020 (17.63%) and lowest in 2021 (-55.25%).
How does Journey Medical Corporation's operating margin compare with similar companies?
Journey Medical Corporation's operating margin (-4.41%) is lower than that of all 5 similar companies listed above. The highest among them is Merck KGaA, with 19.68%.